Genetic Technologies Ltd.
GENE
GENE was delisted on the 16th of October, 2024.
12 hedge funds and large institutions have $1.22M invested in Genetic Technologies Ltd. in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
20% more funds holding
Funds holding: 10 → 12 (+2)
8% less capital invested
Capital invested by funds: $1.33M → $1.22M (-$109K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AGM
Alpine Global Management
New York
|
+$26.7K |
| 2 |
Parallax Volatility Advisers
San Francisco,
California
|
+$4.96K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
+$470 |
| 4 |
Morgan Stanley
New York
|
+$19 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$453K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$52K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$9.08K |
| 4 |
Renaissance Technologies
New York
|
-$4.42K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $1.14M | -$4.42K | -235 | -0.5% |
|
|
AGM
2
Alpine Global Management
New York
| $33K | +$26.7K | +1,422 | New |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $25K | -$453K | -24,076 | -96% |
|
|
4
Parallax Volatility Advisers
San Francisco,
California
| $6K | +$4.96K | +264 | New |
|
|
CG
5
Cutler Group
San Francisco,
California
| $5K | – | – | – |
|
|
LTFS
6
Ladenburg Thalmann Financial Services
Miami,
Florida
| $3K | – | – | – |
|
|
7
UBS Group
Zurich,
Switzerland
| $2K | -$9.08K | -483 | -83% |
|
|
8
Morgan Stanley
New York
| $2K | +$19 | +1 | +1% |
|
|
RE
9
RBC Europe
London,
United Kingdom
| $93 | – | – | – |
|
|
10
Bank of America
Charlotte,
North Carolina
| – | -$52K | -3,036 | Closed |
|
|
11
Simplex Trading
Chicago,
Illinois
| – | +$470 | +25 | New |
|
GENE Hedge Fund Activity: Q4 2017 in Review
12 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q4 2017, worth a combined $1.22M — down 8.2% from $1.33M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new GENE positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 3 trimmed.
The largest buyer was Alpine Global Management, opening a new position worth an estimated $26.7K. The largest seller was Susquehanna International Group, cutting an estimated $453K.
- 12 institutional investors held Genetic Technologies Ltd. (GENE) as of Q4 2017, up from 10 in Q3 2017.
- Funds reported $1.22M of Genetic Technologies Ltd. stock for Q4 2017, down 8.2% quarter-over-quarter.
- 3 funds opened new Genetic Technologies Ltd. positions in Q4 2017 and 1 closed out, a net change of +2 holders.
- The largest Genetic Technologies Ltd. buyer in Q4 2017 was Alpine Global Management, an estimated $26.7K added.
- The largest Genetic Technologies Ltd. seller in Q4 2017 was Susquehanna International Group, an estimated $453K sold.
Based on aggregated 13F filings for Q4 2017.